Abstract

Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates

Author(s): Allen Loyd V Jr

Issue: May/Jun 2020 - Volume 24, Number 3

Page(s): 215-220

Download in electronic PDF format for $75
  • Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates Page 1
  • Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates Page 2
  • Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates Page 3
  • Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates Page 4
  • Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates Page 5
  • Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates Page 6

Abstract

Intravenous admixture compounding requires knowledge of stability, compatibility, and incompatibility issues related to the complete composition and formulation. In evaluating an intravenous admixture, one is not just concerned with the active ingredients but also with all the excipients. Both active pharmaceutical ingredients and excipients used in the formulations of commercially available products may vary among manufacturers and can influence drug compatibility and stability. Clinical pharmaceutics includes the study and application of pharmaceutics to clinical compounding situations to aid in the evaluation of each intravenous admixture. A critical aspect of successful intravenous admixture preparation is the prevention or minimization of particulate matter in the finished product. This article discusses the source, method of prevention, and detection of particulates in intravenous admixtures.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
May/Jun 2020
Pg. 215-220
Author(s): Allen Loyd V Jr
May/Jun 2022
Pg. 219-228
Author(s): Allen Loyd V Jr
Mar/Apr 2021
Pg. 131-139
Author(s): Allen Loyd V Jr
May/Jun 2021
Pg. 222-229
Author(s): Allen Loyd V Jr
Sep/Oct 2023
Pg. 397-409
Author(s): Allen Loyd V Jr
Jul/Aug 2023
Pg. 305-313
Author(s): Allen Loyd V Jr
Jul/Aug 2020
Pg. 305-309
Author(s): Allen Loyd V Jr
Jul/Aug 2021
Pg. 311-317
Author(s): Allen Loyd V Jr
Nov/Dec 2019
Pg. 478-482
Author(s): Allen Loyd V Jr
May/Jun 2023
Pg. 223-229
Author(s): Allen Loyd V Jr
Jan/Feb 2021
Pg. 31-38
Author(s): Allen Loyd V Jr
Jul/Aug 2022
Pg. 309-315
Author(s): Summers Amy
Sep/Oct 2021
Pg. 403-408
Author(s): Allen Loyd V Jr
Jan/Feb 2020
Pg. 44-50
Author(s): Allen Loyd V Jr
Mar/Apr 2023
Pg. 123-139
Author(s): Allen Loyd V Jr
Nov/Dec 2021
Pg. 491-496
Author(s): Allen Loyd V Jr
Sep/Oct 2020
Pg. 397-402
Author(s): Allen Loyd V Jr
Nov/Dec 2020
Pg. 473-478
Author(s): Allen Loyd V Jr
Sep/Oct 2017
Pg. 395-404
Author(s): Akers Michael J
Sep/Oct 2018
Pg. 387-398